These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9089214)

  • 1. Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons.
    Andrus PK; Fleck TJ; Oostveen JA; Hall ED
    J Neurosci Res; 1997 Mar; 47(6):650-4. PubMed ID: 9089214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel pyrrolopyrimidine lipid peroxidation inhibitors U-101033E and U-104067F protect facial motor neurons following neonatal axotomy.
    Smith SL; Oostveen JA; Hall ED
    Exp Neurol; 1996 Oct; 141(2):304-9. PubMed ID: 8812165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.
    Hall ED; Andrus PK; Oostveen JA; Althaus JS; VonVoigtlander PF
    Brain Res; 1996 Dec; 742(1-2):80-8. PubMed ID: 9117424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model.
    Oostveen JA; Dunn E; Carter DB; Hall ED
    J Cereb Blood Flow Metab; 1998 May; 18(5):539-47. PubMed ID: 9591846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.
    Hall ED; Andrus PK; Smith SL; Fleck TJ; Scherch HM; Lutzke BS; Sawada GA; Althaus JS; Vonvoigtlander PF; Padbury GE; Larson PG; Palmer JR; Bundy GL
    J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats.
    Soehle M; Heimann A; Kempski O
    Stroke; 1998 Jun; 29(6):1240-6; discussion 1246-7. PubMed ID: 9626300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN).
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Exp Brain Res; 2000 Jan; 130(1):60-6. PubMed ID: 10638441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia.
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Brain Res; 1999 Jan; 816(2):471-9. PubMed ID: 9878871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats.
    Xiong Y; Peterson PL; Muizelaar JP; Lee CP
    J Neurotrauma; 1997 Dec; 14(12):907-17. PubMed ID: 9475372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective properties of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
    Schmid-Elsaesser R; Zausinger S; Hungerhaber E; Baethmann A; Reulen HJ
    Acta Neurochir Suppl; 1997; 70():176-8. PubMed ID: 9416314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of the pyrrolopyrimidine U-104067F in 3-acetylpyridine-treated rats.
    Sethy VH; Wu H; Oostveen JA; Hall ED
    Exp Neurol; 1996 Jul; 140(1):79-83. PubMed ID: 8682182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the pyrrolopyrimidine lipid peroxidation inhibitor U-101033E on neuronal and astrocytic metabolism and infarct volume in rats with transient middle cerebral artery occlusion.
    Håberg A; Qu H; Hjelstuen MH; Sonnewald U
    Neurochem Int; 2007 Jun; 50(7-8):932-40. PubMed ID: 17241701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin protects GABAergic and dopaminergic neurons in the nigrostriatal system in an experimental rat model of transient focal cerebral ischemia.
    Sabogal AM; Arango CA; Cardona GP; Céspedes ÁE
    Biomedica; 2014; 34(2):207-17. PubMed ID: 24967926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal protection with superoxide dismutase in repetitive forebrain ischemia in gerbils.
    Truelove D; Shuaib A; Ijaz S; Ishaqzay R; Kalra J
    Free Radic Biol Med; 1994 Nov; 17(5):445-50. PubMed ID: 7835751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils.
    Mileson BE; Schwartz RD
    Neurosci Lett; 1991 Jul; 128(1):71-6. PubMed ID: 1922950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
    Sauer H; Oertel WH
    Neuroscience; 1994 Mar; 59(2):401-15. PubMed ID: 7516500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive transient forebrain ischemia in gerbils: delayed neuronal damage in the substantia nigra reticulata.
    Shuaib A; Ijaz S; Kalra J; Code W
    Brain Res; 1992 Mar; 574(1-2):120-4. PubMed ID: 1638388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.